| Merck (Schweiz) AG - Tepmetko 225 mg, Filmtabletten | | 68113 | | 01 | | Tepmetko 225 mg | | Filmtabletten | | L01EX21 | | Tepotinib | | 22.06.2021 | | |
| | Composition | | tepotinibum 225 mg ut tepotinibi hydrochloridum monohydricum 250 mg, mannitolum 455.33 mg, cellulosum microcristallinum, crospovidonum, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, lactosum monohydricum 4.37 mg, macrogola, triacetinum, E 171, E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Tepotinibum | 225 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Tepotinibum | 225 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Rubrum) | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 4.37 mg | | | Macrogola | | | | Magnesii Stearas | | | | Mannitol | 455.33 mg | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Triacetinum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 60 | 5981.89 | 6445.20 | A | LS | Non |
|
|
